Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Saro Armenian"'
Autor:
Alexandre Chan, Kayleen Ports, Ding Quan Ng, Reem Nasr, Steffi Hsu, Saro Armenian, Nicole Baca, David R. Freyer, Dennis John Kuo, Carol Lin, Joel Milam, Jennifer Valerin, Christine Yun, Lilibeth Torno
Publikováno v:
Journal of Adolescent and Young Adult Oncology.
Autor:
Hari K. Narayan, Karyn Sheline, Victor Wong, Dennis Kuo, Sun Choo, Janet Yoon, Kasey Leger, Shelby Kutty, Michael Fradley, Adriana Tremoulet, Bonnie Ky, Saro Armenian, Avirup Guha
Publikováno v:
Pediatric Blood & Cancer. 70
We sought to examine cardiovascular toxicities associated with tyrosine kinase inhibitors in pediatrics. We examined 1624 pediatric adverse events with imatinib, dasatinib, sorafenib, pazopanib, crizotinib, and ruxolitinib reported to the Food and Dr
Autor:
Emily Yang, Anna Dornisch, Laura Nerb, Teresa Helsten, Bonnie N. Kaiser, Paula Aristizabal, Saro Armenian, Lilibeth L. Torno, Nicole M. Baca, Mark C. Genensen, H. Irene Su, Sally A. D. Romero
PurposeOncofertility care for pediatric, adolescent, and young adult cancer patients remains under-implemented across adult and pediatric oncology settings. We pilot tested an electronic health record (EHR)-enabled multi-component oncofertility inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf94c3b22b86db6f8b52b2cc0c2bddc
https://doi.org/10.1101/2022.02.18.22271158
https://doi.org/10.1101/2022.02.18.22271158
Autor:
Esmée C de Baat, Elvira C van Dalen, Renée L Mulder, Melissa M Hudson, Matthew J Ehrhardt, Frederike K Engels, Elizabeth A M Feijen, Heynric B Grotenhuis, Jan M Leerink, Livia Kapusta, Gertjan J L Kaspers, Remy Merkx, Luc Mertens, Roderick Skinner, Wim J E Tissing, Florent de Vathaire, Paul C Nathan, Leontien C M Kremer, Annelies M C Mavinkurve-Groothuis, Saro Armenian
Publikováno v:
de Baat, E C, van Dalen, E C, Mulder, R L, Hudson, M M, Ehrhardt, M J, Engels, F K, Feijen, E A M, Grotenhuis, H B, Leerink, J M, Kapusta, L, Kaspers, G J L, Merkx, R, Mertens, L, Skinner, R, Tissing, W J E, de Vathaire, F, Nathan, P C, Kremer, L C M, Mavinkurve-Groothuis, A M C & Armenian, S 2022, ' Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines : recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group ', The Lancet Child and Adolescent Health, vol. 6, no. 12, pp. 885-894 . https://doi.org/10.1016/S2352-4642(22)00239-5
The Lancet Child & Adolescent Health, 6, 885-894
The Lancet Child & Adolescent Health, 6, 12, pp. 885-894
The Lancet Child & Adolescent Health, 6, 885-894
The Lancet Child & Adolescent Health, 6, 12, pp. 885-894
Item does not contain fulltext Survivors of childhood cancer are at risk of anthracycline-induced cardiotoxicity, which might be prevented by dexrazoxane. However, concerns exist about the safety of dexrazoxane, and little guidance is available on it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e933dd197d23cbe7070b694086dff1e7
https://doi.org/10.1016/S2352-4642(22)00239-5
https://doi.org/10.1016/S2352-4642(22)00239-5